Sempra (SRE) concluded trading on Wednesday at a closing price of $75.86, with 4.62 million shares of worth about $350.41 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -7.09% during that period and on May 07, 2025 the price saw a gain of about 1.05%. Currently the company’s common shares owned by public are about 651.91M shares, out of which, 651.46M shares are available for trading.
Stock saw a price change of 2.14% in past 5 days and over the past one month there was a price change of 18.70%. Year-to-date (YTD), SRE shares are showing a performance of -13.52% which increased to 4.03% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $61.90 but also hit the highest price of $95.77 during that period. The average intraday trading volume for Sempra shares is 5.49 million. The stock is currently trading 4.51% above its 20-day simple moving average (SMA20), while that difference is up 6.89% for SMA50 and it goes to -6.27% lower than SMA200.
Sempra (NYSE: SRE) currently have 651.91M outstanding shares and institutions hold larger chunk of about 90.70% of that.
The stock has a current market capitalization of $49.45B and its 3Y-monthly beta is at 0.64. PE ratio of stock for trailing 12 months is 17.17, while it has posted earnings per share of $4.42 in the same period. Its PEG reads 3.45 and has Quick Ratio of 0.49 while making debt-to-equity ratio of 1.16. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SRE, volatility over the week remained 2.04% while standing at 2.89% over the month.
Stock’s fiscal year EPS is expected to drop by -2.85% while it is estimated to increase by 10.70% in next year. EPS is likely to grow at an annualized rate of 4.98% for next 5-years, compared to annual growth of 3.92% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Citigroup on April 09, 2025 offering a Neutral rating for the stock and assigned a target price range of between $93 and $70 to it. On March 03, 2025, Jefferies Downgrade their recommendations, while on February 27, 2025, Barclays Downgrade their ratings for the stock with a price target of $72. Stock get a Neutral rating from UBS on February 26, 2025.
